CHRISTY BAKER: Open Payments
NPI 1861261729 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,957 in 198 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $2,192 · 2025 $2,957
Food & beverage: $2,957
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 57 | $474 |
| Janssen Biotech, Inc. | 20 | $411 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $345 |
| Lilly USA, LLC | 15 | $326 |
| Ardelyx, Inc. | 17 | $231 |
| Gilead Sciences, Inc. | 15 | $225 |
| Aimmune Therapeutics, Inc. | 12 | $160 |
| Madrigal Pharmaceuticals | 8 | $143 |
| GENZYME CORPORATION | 6 | $138 |
| QOL Medical, LLC | 5 | $112 |
Products named: TREMFYA, ENTYVIO, IBSRELA, RINVOQ, OMVOH, REZDIFFRA, DUPIXENT, Sucraid.
Industry payments across TN — which companies pay providers there.
